|
||
“Do Clinical Trials Work?” The New York Times on Jul. 13, 2013. EVERY spring, some 30,000 oncologists, medical researchers and marketers gather in an American city to showcase the latest advances in cancer treatment. But at the annual meeting of the American Society of Clinical Oncology last month, much of the buzz surrounded a study . . . → Read More: Do Clinical Trials Work?
“Anxiety Lingers Long After Cancer.” By Jan Hoffman, The New York Times. From the shock of the cancer diagnosis onward, depression can take its well-documented toll on patients. Even patients who appear to pack away their fears during the grinding treatment journey to becoming cancer-free concede that when the regimen ends, they unspool emotionally. There . . . → Read More: Anxiety Lingers Long After Cancer
“Sharp Rise in Women’s Deaths From Overdose of Painkillers.” By Sabrina Tavernise, The New York Times. Prescription pain pill addiction was originally seen as a man’s problem, a national epidemic that began among workers doing backbreaking labor in the coal mines and factories of Appalachia. But a new analysis of federal data has found that . . . → Read More: Sharp Rise in Women’s Deaths From Overdose of Painkillers
“Breaking the Seal on Drug Research.” By Katie Thomas, The New York Times. PETER DOSHI walked across the campus of Johns Hopkins University in a rumpled polo shirt and stonewashed jeans, a backpack slung over one shoulder. An unremarkable presence on a campus filled with backpack-toters, he is 32, and not sure where he’ll be . . . → Read More: Breaking the Seal on Drug Research 
The Telegraph recently reported that, “More than 500,000 women at risk of breast cancer because of their family history should take tamoxifen as preventive measure.” The story is based on a new set of guidelines from the National Institute for Health and Care Excellence in the UK recommending chemoprevention drugs to women who have not . . . → Read More: Chemoprevention Is No Magic Bullet
“A Genetic Counselor Explains How Gene Patents Harmed Her Patients.” By Ellen Matloff, MS, Yale Cancer Center, Breast Cancer Action. Editor’s Note: On July 13, 2013, the Supreme Court ruled in our favor to overturn Myriad Genetics’ patents on the “breast cancer genes,” BRCA1 and BRCA2. We were proud to be the only breast cancer . . . → Read More: A Genetic Counselor Explains How Gene Patents Harmed Her Patients
“Our Genes, Their Secrets.” By Eleonore Pauwels, The New York Times. The Supreme Court’s unanimous ruling last Thursday, barring patents on human genes, was a wise and balanced decision that clears away a major barrier to innovation in the areas of biotechnology, drug development and medical diagnostics. But the decision is just a first step . . . → Read More: Our Genes, Their Secrets
“The Health Insurance Shell Game.” By Nortin M. Hadler and Janet Schwartz, Scientific American. The insurance industry had a rocky start a century ago. It was clear that there were untoward events that could befall any of us with catastrophic results, from the incineration of a home to the loss of the ability to maintain . . . → Read More: The Health Insurance Shell Game
“Susan G. Komen® Names Dr. Judith Salerno as President and Chief Executive Officer.” Susan G. Komen Press Release. A nationally known expert in both health policy and research has been named to lead Susan G. Komen, the world’s largest breast cancer organization, as its President and Chief Executive Officer. Susan G. Komen’s Board of Directors . . . → Read More: Susan G. Komen® Names Dr. Judith Salerno as President and Chief Executive Officer
“Poking Holes in Genetic Privacy.” By Gina Kolata, The New York Times. Not so long ago, people who provided DNA in the course of research studies were told that their privacy was assured. Their DNA sequences were on publicly available Web sites, yes, but they did not include names or other obvious identifiers. These were . . . → Read More: Poking Holes in Genetic Privacy |
||
| Copyright © 2026 Breast Cancer Consortium – Archives - All Rights Reserved. Privacy Policy | ||